Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
SDG 2 — Zero Hunger
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
SDG 10 — Reduced Inequalities
SDG 17 — Partnerships for the Goals
This track will explore the advancements in precision medicine tailored to diabetes treatment. Discussions will focus on genetic, metabolic, and environmental factors that influence individualized therapeutic approaches.
This session will highlight the role of digital health technologies in enhancing diabetes management. Topics will include mobile health applications, telemedicine, and remote patient monitoring.
This track will investigate the potential of regenerative medicine in reversing diabetes complications. Emphasis will be placed on stem cell therapy and tissue engineering advancements.
This session will cover the latest pharmacological developments aimed at improving glycemic control and reducing diabetes-related complications. Participants will discuss novel drug mechanisms and their clinical implications.
This track will examine evidence-based lifestyle interventions that effectively prevent and manage diabetes. Focus will be on dietary modifications, physical activity, and behavioral health strategies.
This session will address the integration of advanced technologies into diabetes care practices. Topics will include artificial intelligence, wearable devices, and data analytics for personalized treatment.
This track will emphasize the importance of patient-centered care in diabetes management. Discussions will focus on shared decision-making, patient education, and the role of support systems.
This session will present emerging global research trends and their implications for diabetes treatment. Participants will share insights on cross-cultural studies and international collaborations.
This track will explore cutting-edge therapeutic options currently in development for diabetes management. Focus will be on novel agents and their mechanisms of action.
This session will discuss the impact of health policy on diabetes care and treatment accessibility. Participants will analyze current policies and propose recommendations for improvement.
This track will focus on innovative educational strategies for diabetes patients and healthcare providers. Emphasis will be placed on effective communication, technology use, and community engagement.